Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ORCHPHARMA.NS
HoldHot AirOrchid Pharma Limited · Healthcare · India · $517M · Avg Vol: $850K/d
45
StockRankGet insider-trade alerts
Q
38
V
18
M
82
P/E (TTM)
183.0x
ROE
1.6%
D/E
0.3x
Dividend %
—
COMPANY DESCRIPTION
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.7B | 8.2B | 9.2B | 8.1B | 6.8% | 6.1B | 14.4B | 20.0B | 57.2% |
| EPS (INR) | 11.35 | 19.06 | 19.65 | 4.05 | -29.1% | 5.62 | — | — | — |
| Shares | 40.8M | 50.7M | 50.7M | 50.7M | +24.3% | 50.7M | — | — | — |
| Debt | 3.3B | 1.4B | 1.7B | 3.6B | 3.0% | 3.6B | — | — | — |
| Equity | 6.9B | 11.7B | 12.7B | 12.9B | 23.2% | — | — | — | — |
| Op CF | 183.4M | 1.3B | 192.2M | 1.0B | 76.7% | 1.0B | — | — | — |
| Inv CF | -312.1M | -3.1B | -269.3M | -2.9B | — | — | — | — | — |
| Fin CF | 311.7M | 1.7B | 252.2M | 1.7B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+2.3%
SMA 50SMA 200
Close
$10.74
RSI (14)
56.5
52W High
$11.87
From 52W High
0.9%
SCORE BREAKDOWN
Quality
38
ROIC
1.4%47.0
ROE
1.6%47.1
GP/Assets
16.8%37.4
Op. Margin
-12.3%27.0
FCF/Assets
-14.8%25.3
Piotroski
431.0
Int. Cover
1.8x41.7
D/E Ratio
0.28x42.6
Current Ratio
2.45x47.5
Value
18
P/E (TTM)
183.0x3.6
EV/EBITDA
79.6x6.4
P/FCF
—N/A
P/B
4.0x35.9
P/S
8.6x28.6
Div Yield
—N/A
Momentum
82
52W High %
90%85.1
RS 6M
105%96.9
SMA 50/200
1.27x91.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+650%97.0
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$517M
P/E (Forward)
24.4x
Gross Margin
53.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ORCHPHARMA.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ORCHPHARMA.NS | Orchid Pharma Limited(you) | $517M | 45 | Hold |
| GUJTHEM.NS | Gujarat Themis Biosyn Limited | $622M | 52 | Hold |
| NOVARTIND.NS | Novartis India Limited | $475M | 30 | Sell |
| SHUKRAPHAR.NS | Shukra Pharmaceuticals Limited | $252M | 38 | Hold |
| SUVEN.NS | Suven Life Sciences Limited | $1.1B | 34 | Sell |
| SUDEEPPHRM.NS | Sudeep Pharma Limited | $1.6B | 41 | Hold |
| INDOCO.NS | Indoco Remedies Limited | $237M | 57 | Hold |
| GUFICBIO.NS | Gufic Biosciences Limited | $466M | 71 | Buy |
| AARTIPHARM.NS | Aarti Pharmalabs Limited | $829M | 65 | Buy |
| SIGACHI.NS | Sigachi Industries Limited | $140M | 39 | Hold |
Peer medians: ROE 11.9% · P/E 42.5x · Gross margin 59.4%